Trials / Completed
CompletedNCT01412320
Cocoa Flavanols in Renal Disease
The Impact of Dietary Flavanols on Cardiovascular Dysfunction in End-stage Renal Disease
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Klinik für Kardiologie, Pneumologie und Angiologie · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Purpose of the study is to characterize the potential acute and long-term improvement of dietary flavanols on vascular function in patients with end-stage renal disease (ESRD). Patients will twice daily receive either a flavanol-poor or a flavanol-rich drink. In a double blind, placebo-controlled crossover study the safety, efficacy and acute beneficial effects of flavanol ingestion will be assessed in 10 patients with ESRD. In a 30 day long-term, double blind, placebo-controlled parallel study the chronic effects of dietary flavanols on vascular function in 52 patients with ESRD will be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cocoa | dissolved in water twice daily |
| OTHER | Cocoa | dissolved in water twice daily |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2011-08-09
- Last updated
- 2013-11-13
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01412320. Inclusion in this directory is not an endorsement.